Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IACH MATH 2020 | MRD in AML: ELN recommendations

Arnon Nagler, MD, Sheba Medical Center, Tel-Aviv, Israel, gives an overview of the European LeukemiaNet (ELN) recommendations on measurable residual disease (MRD) in acute myeloid leukemia (AML). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).